Invention Grant
- Patent Title: Method of treating cancer
-
Application No.: US14443602Application Date: 2013-11-19
-
Publication No.: US09889180B2Publication Date: 2018-02-13
- Inventor: Qiang Yu , Zhen Ning Wee
- Applicant: Agency for Science, Technology and Research
- Applicant Address: SG Singapore
- Assignee: Agency for Science, Technology and Research
- Current Assignee: Agency for Science, Technology and Research
- Current Assignee Address: SG Singapore
- Agency: Schwegman Lundberg & Woessner, P.A.
- Priority: SG201208522-1 20121119
- International Application: PCT/SG2013/000490 WO 20131119
- International Announcement: WO2014/077784 WO 20140522
- Main IPC: A61K31/713
- IPC: A61K31/713 ; A61K31/706 ; A61K31/437 ; A61K38/21 ; G01N33/574 ; C07K16/40 ; C07K14/57 ; C12Q1/68 ; C12N15/113
Abstract:
The present invention relates to a pharmaceutical composition comprising a histone-lysine N-methyltransferase EZH2 (enhancer of zeste homolog 2) inhibitor and an enhancer of interferon-gamma receptor activity. The invention also relates to method of treating a patient having cancer, comprising administration of the pharmaceutical composition.
Public/Granted literature
- US20150258175A1 METHOD OF TREATING CANCER Public/Granted day:2015-09-17
Information query
